Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PBI 06150

Next Previous
Drug Profile

PBI 06150

Alternative Names: PBI-06150

Latest Information Update: 04 Sep 2026

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Phoenix Biotechnology
  • Developer Phoenix Biotechnology; Texas Biomedical Research Institute; University of Texas Medical Branch
  • Class Antivirals; Cardiac glycosides; Polyphenols
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical COVID 2019 infections

Most Recent Events

  • 02 Sep 2026 Preclinical development in COVID-2019-infections in ongoing in USA (Sublingual) (Phoenix Biotechnology pipeline, September 2026)
  • 02 Sep 2026 Phoenix Biotechnology has patent protection for composition of PBI 06150 (Phoenix Biotechnology pipeline, September 2026)
  • 28 Apr 2025 No recent reports of development identified for preclinical development in COVID-2019-infections in USA (Sublingual)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top